MyAverix Finance
XETRA · Healthcare
QIAGEN NV (QIA)
Diagnostics & Research
QIAGEN NV (QIA) is listed on XETRA in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-24, reported market cap is $6.25B, P/E ratio is 17.92, net margin is 19.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for QIA
QIAGEN NV (QIA) — FAQ
What is QIAGEN NV's market cap?
QIAGEN NV (QIA) has a reported market cap of $6.25B (data as of 2026-05-24).
What is QIA's P/E ratio?
The price-to-earnings (P/E) ratio for QIAGEN NV (QIA) is 17.92 (data as of 2026-05-24).
Does QIAGEN NV pay a dividend?
Dividend yield is not available in the current snapshot for QIAGEN NV (QIA). Check the MyAverix Finance app for the latest dividend data.
What sector is QIAGEN NV in?
QIAGEN NV (QIA) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is QIA listed on?
QIA is listed on XETRA.
What is QIAGEN NV's net margin?
QIAGEN NV (QIA) reports a net margin of 19.2% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.